The shares of drug maker Dyax are surging after the company last night reported data from a Phase 1b clinical trial of its DX-2930 drug, a treatment for hereditary angioedema...
Cable industry stocks are in focus this morning after a number of deals were announced...
Shares of Hyperion Therapeutics rose 8% this morning after the company announced that it had agreed to be acquired for $46 per share by Horizon Pharma.
The shares of BioMarin are climbing after a blog reported last night that Shire is considering offering to acquire the company.
Twitter is emerging as a battleground stock with Rosenblatt today starting coverage with a Buy rating while Stifel kept its Sell rating highlighting what it sees as weak operating metrics.
A group of 3D printer makers will hold small group meetings and one-on-one meetings with investors at the Jefferies 3D Printing Summit tomorrow.
Facebook is holding its F8 Developer Conference in San Francisco, California, on Wednesday, March 25 through Thursday, March 26.
American Express' investor day, slated to be held this Wednesday, March 25, could provide a positive catalyst for the stock, Deutsche Bank wrote in a note to investors.
The shares of Biogen are rallying after the company reported results for a Phase 1b study of its Alzheimer's drug, BIIB-037.
Shares of coffee giant Starbucks hit a new all-time high of $97.69 earlier this morning following the company's investor day meeting yesterday.